Spots Global Cancer Trial Database for Topotecan and Melphalan for Retinoblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Topotecan and Melphalan for Retinoblastoma
Official Title: Choice of Topotecan or Melphalan in Retinoblastoma Patients
Study ID: NCT04799002
Study Description
Brief Summary: The purpose of this study is to evaluate topotecan and melphalan for retinoblastoma patients.
Detailed Description: To evaluate the effectiveness and complications of topotecan and melphalan for intraocular injection in retinoblastoma patients.
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sun Yat-sen University, Guangzhou, Guangdong, China
Contact Details
Name: Huashen Yang
Affiliation: Sun Yat-sen University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
